| scholarly article | Q13442814 |
| P50 | author | Wenhu Liu | Q89477384 |
| P2093 | author name string | Jianwu Zhang | |
| Zhenzhong Liu | |||
| Jiangbei Yuan | |||
| Jinxia Chang | |||
| P2860 | cites work | An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients. | Q50801948 |
| HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research. | Q51541370 | ||
| Profiling Prostate Cancer Therapeutic Resistance. | Q52644478 | ||
| A proteomic landscape of diffuse-type gastric cancer. | Q52727768 | ||
| Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). | Q53985281 | ||
| Critical appraisal of trastuzumab in treatment of advanced stomach cancer | Q24604411 | ||
| Role of EMT in Metastasis and Therapy Resistance | Q26772923 | ||
| PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. | Q27824819 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Molecular targeted therapy for the treatment of gastric cancer | Q28072433 | ||
| Proteogenomic characterization of human colon and rectal cancer | Q28244320 | ||
| The ErbB/HER family of protein-tyrosine kinases and cancer | Q28302611 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Universal sample preparation method for proteome analysis | Q29615662 | ||
| Mass-spectrometry-based draft of the human proteome | Q29617249 | ||
| Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials. | Q30857631 | ||
| ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription | Q33247340 | ||
| Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. | Q34045380 | ||
| Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells | Q34492498 | ||
| The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells | Q34552289 | ||
| Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. | Q35345071 | ||
| HER2 therapy: molecular mechanisms of trastuzumab resistance. | Q35633712 | ||
| Adjuvant trastuzumab in HER2-positive breast cancer | Q35710898 | ||
| Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications | Q36088788 | ||
| Role of ErbB Receptors in Cancer Cell Migration and Invasion | Q36311027 | ||
| Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). | Q36426509 | ||
| Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer | Q36476312 | ||
| Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells | Q37066536 | ||
| A fast workflow for identification and quantification of proteomes. | Q37072912 | ||
| Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT). | Q37076868 | ||
| HER2-positive gastric cancer | Q37468290 | ||
| p95HER2 and breast cancer | Q37846003 | ||
| Targeting the Wnt/β-catenin signaling pathway in human cancers | Q37864329 | ||
| Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer | Q37988897 | ||
| Mass spectrometry based proteomics, background, status and future needs | Q38038506 | ||
| The Wnt/β-catenin pathway in ovarian cancer: a review. | Q38152532 | ||
| Molecularly targeted cancer therapy: some lessons from the past decade | Q38173136 | ||
| A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond | Q38221411 | ||
| Targeting HER2 for the treatment of breast cancer | Q38317974 | ||
| Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance | Q38703402 | ||
| Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. | Q38807957 | ||
| Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance | Q38860383 | ||
| β2-AR signaling controls trastuzumab resistance-dependent pathway | Q38896403 | ||
| The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway | Q38962587 | ||
| Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress | Q39097271 | ||
| β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. | Q39145972 | ||
| Deep proteome and transcriptome mapping of a human cancer cell line | Q39446248 | ||
| Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells | Q40344963 | ||
| Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer | Q43880463 | ||
| Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. | Q46021160 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 7 | |
| P921 | main subject | trastuzumab | Q412616 |
| P577 | publication date | 2018-07-06 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer | |
| P478 | volume | 19 |
| Q89691147 | Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition |
| Q92917056 | Current Updates on Trastuzumab Resistance in HER2 Overexpressing Breast Cancers |
| Q89636147 | The Dynll1-Cox4i1 Complex Regulates Intracellular Pathogen Clearance via Release of Mitochondrial Reactive Oxygen Species |
Search more.